The first scales evaluating the patient conditions were designed in the 80-ties of the previous century and quickly became popular at intensive care units (ICUs) [1, 2]. Since that time, numerous new scales have been created or the existing ones modified in order to provide most accurate assessment of patients. They are the tools for validation of the therapeutic procedures used as well as for monitoring the quality and costs of treatment. The standardised assessment measures are also extremely useful during prospective and retrospective studies, which, in turn, contribute to implementation of increasingly effective treatment options, both interventional and pharmacological [3].